… To guide efficient resource allocation, an economic evaluation was … in the management
of AF patients in Greece and the present paper presents the results of this economic analysis. …

… Dabigatran etexilate may represent a cost-effective choice for the management of patients
with atrial fibrillation in Greece… conduct an economic analysis comparing treatment with clopi…

… In conclusion, model-based economic evaluations on dabigatran vs. VKAs for the … Economic
evaluation of dabigatran etexilate in the management of atrial fibrillation in Greece. Hellenic …

… in patients with atrial fibrillation: a Greek perspective. Am J Cardiovasc Drugs. 2017;17(2):123-33. …
This model is used for economic evaluations in healthcare systems, considering the …

… . Economic evaluation of dabigatran etexilate in the management of atrial fibrillation in
Greece. Hellenic J Cardiol 2013;54:289–300.pmid:http://www.ncbi.nlm.nih.gov/pubmed/…

… Last but not least, the economic impact of drug administration in Greece of economic crisis is
major. In a study of Andrikopoulos et al. … Economic Evaluation of Dabigatran Etexilate in the …

… Dabigatran etexilate may represent a cost-effective choice for the management of patients
with atrial fibrillation in Greece… conduct an economic analysis comparing treatment with clopi…

… Status of anticoagulation therapy for patients with atrial fibrillation in north-western Greece.
… of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: …

… analysis, the same distribution of DOAC use was assumed. Daily doses of dabigatran
etexilate … (For elaboration of the estimation of costs associated with PSM and DOAC treatment, …

… economic impact of NOAs for stroke prevention before their introduction, but, in the Italian
setting, a comprehensive comparative analysis and a full economic evaluation … the economic …